Antigen

Nanomaterials: A New Frontier in Cancer Immunotherapy

by

Researchers at Nankai University have developed a framework for integrated nanomaterials designed to overcome the physiological and immune-based barriers that frequently limit the effectiveness of cancer immunotherapy. Published April 24, 2026, in the Chinese Journal of Polymer Science, the study outlines how coordinated nanomaterial design can improve drug delivery, antigen presentation, and tumor microenvironment reprogramming … Read more

New Breast Cancer Classification Predicts Immunotherapy Success

by

Researchers from the Department of Breast Surgery at Fudan University Shanghai Cancer Center and the Department of Oncology at Shanghai Medical College, Fudan University have developed a new classification system for breast cancer based on the cancer-immunity cycle (CIC). Published in Cancer Biology & Medicine in 2026, this framework uses a “CIC score” to categorize … Read more

Universal Sarbecovirus Vaccine Shows Promise in First Human Trial

by

The End of “Reactive” Medicine: How AI is Ending the Pandemic Chase For decades, humanity has played a high-stakes game of cat-and-mouse with viruses. When a new pathogen emerges, scientists rush to sequence it, manufacture a targeted vaccine, and scramble to distribute it—often just as the virus begins to mutate into something new. We see … Read more

PSMA PET: Detecting High-Risk Prostate Cancer Bone Metastases

by

The Invisible Threat: Why Standard Scans Are Failing Prostate Cancer Patients Imagine receiving a report from your doctor stating that your bone scan is perfectly clear. You breathe a sigh of relief, thinking the cancer is contained. But beneath the surface, a silent progression is already underway. This is the harrowing reality for a significant … Read more

Predictive Model Optimizes PSMA Therapy for Prostate Cancer

by

Revolutionizing Prostate Cancer Care: The Future of Personalized Radiotherapy For patients battling metastatic castration-resistant prostate cancer (mCRPC), the path to effective treatment is often complex. A breakthrough in machine learning is now offering a glimpse into a more precise future, where clinicians can estimate radiation doses to tumors and healthy organs before therapy even begins. … Read more

Cytokine-armored CAR-T cell therapy successfully attacks aggressive brain tumors in mice

by

Beyond Blood Cancers: The New Frontier of Solid Tumor Therapy For years, CAR-T cell therapy has been hailed as a miracle for certain blood cancers, but solid tumors—particularly aggressive brain cancers like glioblastoma—have remained stubbornly resistant. The challenge isn’t just the cancer itself, but the “shield” these tumors build around themselves to hide from the … Read more

New mRNA vaccine strategy dramatically amplifies cancer-fighting T cells

by

The New Frontier of Immunotherapy: Reprogramming the Body to Fight Cancer For decades, vaccines have relied on adjuvants—substances added to a vaccine to create a stronger immune response. However, traditional adjuvants often provide only short-lived stimulation. A groundbreaking shift is now occurring, moving away from external triggers toward “reprogramming” the immune system from the inside … Read more

Kenyan bat coronavirus uses human CEACAM6 to enter cells, raising spillover concerns

by

Beyond ACE2: The New Frontier of Viral Entry For years, the scientific community’s focus on coronaviruses has been heavily weighted toward beta-coronaviruses and the well-known ACE2 receptor. However, recent breakthroughs are shifting the map. Researchers have uncovered a different “lock” that certain animal viruses can pick to enter human cells: the CEACAM6 receptor. This discovery … Read more

Targeting glutamine metabolism enhances CAR-macrophage cancer therapy

by

The New Frontier of Immunotherapy: Fueling the Fight Against Solid Tumors For years, the promise of CAR-T cell therapy has transformed the treatment of blood cancers. Still, solid tumors have remained a stubborn fortress, protected by a hostile tumor microenvironment (TME) that effectively starves and exhausts immune cells. The latest breakthrough in metabolic engineering is … Read more

Pre-existing activation states shape functional heterogeneity of human Vγ9Vδ2 T cells

by

The Future of Cancer Immunotherapy: Harnessing the Power of Vγ9Vδ2 T Cells A new wave of cancer treatments is emerging, focusing on leveraging the body’s own immune system to fight tumors. Central to this revolution are Vγ9Vδ2 T cells, a unique subset of immune cells showing remarkable promise in preclinical and clinical studies. Recent research, … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]